Contract for supply of herpes zoster (shingles) vaccine(recombinant, adjuvanted)

A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE

Source
Find a Tender
Type
Contract (Supply)
Duration
not specified
Value
£66M
Sector
HEALTH
Published
15 Jan 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

Bedford, UK

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

The provision of herpes zoster (shingles) vaccine(recombinant, adjuvanted)

Total Quantity or Scope

The provision of herpes zoster (shingles) vaccine(recombinant, adjuvanted) deliveries will be required from 1 April 2021 to 31 March 2023, with an option to extend for up to an additional 24 months.

Award Detail

1 Glaxosmithkline (Brentford)
  • Num offers: 1
  • Value: £66,131,483

Renewal Options

The contract has the option to be extended for up to an additional 24 months

Award Criteria

Comparison with specification _
Volume and delivery _
Risk to programme _
Risk management and contingency plans _
Vaccine price _

CPV Codes

  • 33651600 - Vaccines

Indicators

  • Options are available.
  • Award on basis of price and quality.

Other Information

The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.

Reference

Domains